Genentech

Genentech, Inc.
Company type	Subsidiary
Traded as	Nasdaq: DNA
Industry	Biotechnology
Founded	1976
Headquarters	South San Francisco, California, United States
Key people	Ashley Magargee; (interim CEO); Ed Harrington; Levi Garraway; Stephen Williams; Sean Johnston; Severin Schwan; (chairman of Genentech Board of Directors, CEO of Roche Group); Anna Batt; Aviv Regev;
Products	Avastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Polivy, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax
Revenue	$26.4 billion (2020)
Number of employees	13,539 (July 2021)
Parent	Roche
Website	gene.com
	Footnotes / references;

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.^[6] Historically, the company is regarded as the world's first biotechnology company.^[7]

As of July 2021, Genentech employed 13,539 people.^[8]

^ "DEPARTURE OF ALEXANDER HARDY & APPOINTMENT OF ASHLEY MAGARGEE AS INTERIM CHIEF EXECUTIVE OFFICER GENENTECH". Genentech. Retrieved November 3, 2023.
^ Cite error: The named reference fiercebiotech was invoked but never defined (see the help page).
^ Cite error: The named reference Press_Regev was invoked but never defined (see the help page).
^ "Genentech".
^ "FORM 10-K".
^ "About Us". Gene.com. Archived from the original on August 4, 2014. Retrieved August 22, 2014.
^ Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
^ "Working at Genentech". Great Place to Work. Retrieved November 18, 2021.

[1] "DEPARTURE OF ALEXANDER HARDY & APPOINTMENT OF ASHLEY MAGARGEE AS INTERIM CHIEF EXECUTIVE OFFICER GENENTECH". Genentech. Retrieved November 3, 2023.

[fiercebiotech-2] Cite error: The named reference fiercebiotech was invoked but never defined (see the help page).

[Press_Regev-3] Cite error: The named reference Press_Regev was invoked but never defined (see the help page).

[4] "Genentech".

[5] "FORM 10-K".

[6] "About Us". Gene.com. Archived from the original on August 4, 2014. Retrieved August 22, 2014.

[7] Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.

[8] "Working at Genentech". Great Place to Work. Retrieved November 18, 2021.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Genentech

Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.